Methods of minimal residual disease (MRD) detection in childhood haematological malignancies

The appropriate management of haematological disorders must rely on a precise and long-term monitoring of the patient's response to chemotherapy and radiotherapy. Clinical data are not sufficient and that is why in the last decade it became the most important to improve the knowledge of haemato...

Full description

Saved in:
Bibliographic Details
Published in:Journal of applied genetics 2007-01, Vol.48 (1), p.77-83
Main Authors: Jółkowska, Justyna, Derwich, Katarzyna, Dawidowska, Małgorzata
Format: Article
Language:English
Subjects:
Chemotherapy
Child
Children
Gene Rearrangement, B-Lymphocyte
Gene Rearrangement, T-Lymphocyte
Genetic Techniques
Health services
Hematologic Neoplasms - diagnosis
Hematologic Neoplasms - genetics
Hematological diseases
Hematology
Humans
Minimal residual disease
Neoplasm, Residual - diagnosis
Neoplasm, Residual - genetics
Oncogene Fusion
Polymerase Chain Reaction - methods
Radiation therapy
Translocation, Genetic
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The appropriate management of haematological disorders must rely on a precise and long-term monitoring of the patient's response to chemotherapy and radiotherapy. Clinical data are not sufficient and that is why in the last decade it became the most important to improve the knowledge of haematological diseases on the basis of molecular techniques and molecular markers. The presence of residual malignant cells among normal cells is termed minimal residual disease (MRD). Nowadays a great progress has been made in the treatment of malignant diseases and in the development of reliable molecular techniques, which are characterised by high sensitivity (10-3- 10-6) and ability to distinguish between normal and malignant cells at diagnosis and during follow-up. Especially, MRD data based on quantitative analysis (RQ-PCR, RT-RQ-PCR) appear to be crucial for appropriate evaluation of treatment response in many haematological malignancies. Implementation of standardized approaches for MRD assessment into routine molecular diagnostics available in all oncohaematological centres should be regarded nowadays a crucial point in further MRD study development.
ISSN:1234-1983
2190-3883
DOI:10.1007/BF03194661